10 Undervalued Dividend Growth Stocks: March 2025
Source: SeekingAlpha
2025-03-19 09:00:00 ET
Summary
- I rank a selection of undervalued dividend growth stocks in Dividend Radar and present the ten top-ranked stocks for consideration.
- I use two valuation screens, one based on my fair value estimate, and another comparing each stock's forward dividend yield with its 5-year average dividend yield.
- To rank stocks, I do a quality assessment and sort candidates by quality scores, breaking ties with additional metrics.
- This month, I'm presenting the ten top-ranked undervalued dividend growth stocks yielding at least 4%.
This monthly article series identifies 10 Undervalued Dividend Growth Stocks for further research and possible investment. I present the top-ranked candidates based on quality scores. These high-quality, undervalued dividend growth stocks are good candidates for your dividend growth portfolio. As always, I recommend doing your own analysis before investing in these stocks.
| Since this is a monthly article series with an established format, certain parts and descriptions of methodology are repeated. Regular readers can safely skip the template introduction and Valuation and Ranking section. |
Read the full article on Seeking Alpha
For further details see:
10 Undervalued Dividend Growth Stocks: March 2025
Bristol-Myers Squibb Company
NASDAQ: BMY
BMY Trading
0.36% G/L:
$59.35 Last:
3,245,443 Volume:
$59.49 Open:
BMY Latest News
BMY Stock Data
$123,325,918,376
2,034,328,000
N/A
1394
N/A
Pharmaceuticals
Healthcare
US
Princeton
